Questions about dantrolene for neuroleptic malignant syndrome.
D014150:Antipsychotic Agents / Q000009:adverse effects*; D001480:Basal Ganglia Diseases / Q000139:chemically induced* / Q000188:drug therapy; D003620:Dantrolene / Q000627:therapeutic use*; D005334:Fever / Q000139:chemically induced / Q000188:drug therapy*; D006801:Humans; D008305:Malignant Hyperthermia / Q000188:drug therapy
D014150:Antipsychotic Agents; D003620:Dantrolene